Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care [NA]
A completed trial evaluating electronic health record–based interventions to improve follow-up in primary care for patients with colon cance…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating dasatinib plus LHRH analogue therapy in high-risk localized prostate cancer was terminated with results…
-
CLINICAL_TRIALS research · 2016-02-03Clinical Trial Update: Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup
This completed clinical trial evaluated the use of modern MRI in diagnosing prostate cancer in a Danish setting.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer [Phase 1]
A Phase I trial evaluating the safety, tolerability, anti-tumor activity, and pharmacokinetics of Foxy-5 in metastatic breast cancer, colore…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer [Phase 3]
A Phase 3 trial comparing adjuvant radiation therapy to watchful waiting after radical prostatectomy in high-risk prostate cancer; no result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Rhabdomyolysis and Robot-assisted Radical Prostatectomy
A completed clinical trial evaluated the risk of rhabdomyolysis associated with robot-assisted radical prostatectomy, sponsored by Umraniye …
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Phase 2]
A Phase 2 trial evaluating chemotherapy, hormone therapy, and radiation therapy for locally advanced prostate cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial- [NA]
A randomized blinded trial assessing whether dexmedetomidine influences heart-rate corrected QT interval prolongation during robotic-assiste…
-
CLINICAL_TRIALS withdrawal · 2016-01-29Clinical Trial Update: Physical Activity Intervention in African American Men After Radical Prostatectomy [NA]
A clinical trial (NCT02621684) evaluating a physical activity intervention for African American men after radical prostatectomy for prostate…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Autologous Natural Killer T Cells Infusion for the Treatment of Cancer [NA]
Clinical trial update on autologous natural killer T cell infusion for cancer with unknown status at this time.
-
CLINICAL_TRIALS research · 2016-01-27Clinical Trial Update: CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) [Phase 1, Phase 2]
A Phase 1/2 clinical trial (CEPTAS) evaluating the addition of temsirolimus to standard docetaxel therapy for prostate cancer has completed.
-
FDA approval · 2016-01-22FDA Approved: XOFIGO — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for XOFIGO (radium Ra-223 dichloride) from Bayer HealthCare Pharmaceuticals, updating its labeling/i…
-
CLINICAL_TRIALS withdrawal · 2016-01-22Clinical Trial Update: Robotic Athermal Nerve-Sparing Radical Prostatectomy [NA]
The clinical trial NCT02079155 evaluating Robotic Athermal Nerve-Sparing Radical Prostatectomy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and Biomarkers [NA]
This update summarizes a completed clinical trial evaluating the combination of magnetic resonance imaging and biomarkers to improve the dia…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial assessed the combination of everolimus with gefitinib in patients with progressive glioblastoma and progressive metastatic…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients [Phase 1, Phase 2]
Phase I/II study evaluating azacitidine, docetaxel, and prednisone in metastatic prostate cancer was terminated. Results were posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Study of Irofulven in Patients With Hormone-refractory Prostate Cancer [Phase 2]
A Phase 2 study of irofulven in hormone-refractory prostate cancer has been completed. The document provides the trial status and sponsor de…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]
Phase 1 safety study of an antisense product in multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations [NA]
This completed clinical trial update discusses surgical and anesthetic considerations for outpatient radical prostatectomy in men with prost…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration [Phase 1]
Phase 1 trial update describing inter-SPORE collaboration evaluating novel PET/CT imaging agents and MR spectroscopy/MRI for prostate cancer…
-
FDA approval · 2016-01-12FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA has approved a supplemental application for Firmagon (degarelix) filed by Ferring Pharmaceuticals Inc. This approval represents an u…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Open Label Prostate Cancer Study [Phase 1]
An open-label Phase 1 clinical trial for prostate cancer sponsored by AstraZeneca has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions
This update notes that the trial evaluating NMR spectroscopy of semen and prostatic secretions for diagnosing prostate cancer has been termi…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy [Phase 1]
A phase 1 clinical trial evaluated high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer in patients previ…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence [NA]
This completed clinical trial evaluated the effects of Pilates on pelvic floor muscle strength as a treatment for urinary incontinence follo…